Over four years ago, the International Society of Glomerular Disease (ISGD) began as a shared idea and vision: to create a global home for clinicians and researchers focused on glomerular disease, and to accelerate progress through ...

Today marks a turning point for people living with focal segmental glomerulosclerosis (FSGS). More than a hundred years after the disease was first defined, the U.S. Food and Drug Administration (FDA) has granted its first ever approval of ...

The recent vasculitis conference delivered important advances in classification, pathogenesis, therapeutics, and precision medicine in ANCA-associated vasculitis (AAV) and related glomerular diseases. Below is a synthesis of key ...